023910.KQ
Daihan Pharmaceutical Co.,Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 25,000.00
+0.40%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 5.37x
- P/E 2027E
- 5.07x
- P/E 2028E
- 4.79x
- P/S forward
- 2.74x
Trailing multiples
Trailing twelve months
- P/E TTM
- 5.34x
- PEG TTM
- 0.52x
- Price / book
- 0.48x
- Price / sales
- 0.68x
- Price / cash flow
- 3.94x
Enterprise value
- Enterprise value
- KRW 32.3B
- EV / sales
- 0.15x
- EV / EBITDA
- 0.75x
- EV / EBIT
- 1.07x
- Market cap
- KRW 147.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026